QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文 CANCER MEDICINE, 2022 作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan 收藏  |  浏览/下载：20/0  |  提交时间：2022/12/23 EGFR-TKIs  non-small cell lung cancer (NSCLC)  real-world study  survival outcome   Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review 期刊论文 JOURNAL OF ONCOLOGY, 2022, 卷号: 2022 作者:  Hu, Shumin;  Gong, Jiali;  Zhu, Xiu;  Lu, Hongyang 收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23 A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Lu, S.;  Zhang, Y.;  Zhang, G.;  Zhou, J.;  Cang, S. 收藏  |  浏览/下载：23/0  |  提交时间：2022/12/23 third-generation EGFR-TKI  befotertinib  T790M   High-dose Aumolertinib as First-line Treatment in Patients With Brain Metastases Associated With EGFR Mutated NSCLC 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17 作者:  Fan, Y. 收藏  |  浏览/下载：6/0  |  提交时间：2022/12/23 NSCLC  EGFR TKI  Brain Metastases   Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文 BMC CANCER, 2022, 卷号: 22 作者:  Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong 收藏  |  浏览/下载：21/0  |  提交时间：2022/12/23 Clinical and molecular features  Efficacy and outcome  EGFR T790M mutation  Non-small-cell lung cancer  Osimertinib   Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文 BMC PULMONARY MEDICINE, 2022, 卷号: 22 作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan 收藏  |  浏览/下载：18/0  |  提交时间：2022/12/23 Non-small cell lung cancer  Prognosis  Angiogenesis  Tyrosine kinase inhibitors   HER2 exon 20 insertion mutations in lung adenocarcinoma with leptomeningeal metastasis: a case report and response to poziotinib 期刊论文 ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11 作者:  Fan, Ying;  Qin, Jing;  Han, Na;  Lu, Hongyang 收藏  |  浏览/下载：17/0  |  提交时间：2022/12/23 Leptomeningeal metastasis (LM)  cerebrospinal fluid  HER2 exon 20 insertion mutations  poziotinib  case report   A phase II study of tislelizumab plus chemotherapy in EGFR mutated advanced non-squamous NSCLC patients failed to EGFR TKI therapies: First analysis 期刊论文 ANNALS OF ONCOLOGY, 2021, 卷号: 32 作者:  Han, B.;  Tian, P.;  Zhao, Y.;  Yu, X.;  Guo, Q. 收藏  |  浏览/下载：30/0  |  提交时间：2022/01/10 Liquid chromatography-mass spectrometry based metabolic characterization of pleural effusion in patients with acquired EGFR-TKI resistance 期刊论文 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 卷号: 202 作者:  Li, Na;  Mao, Weimin;  Gao, Yun;  Wang, Ding;  Song, Zhengbo 收藏  |  浏览/下载：50/0  |  提交时间：2021/08/31 Lung cancer  EGFR-TKI  Resistance  Pleural effusion  Metabolomics  Biomarker   D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase II study (NCT03861156). 期刊论文 CANCER RESEARCH, 2021, 卷号: 81 作者:  Lu, Shun;  Zhang, Yiping;  Zhang, Guojun;  Zhou, Jianying;  Cang, Shundong 收藏  |  浏览/下载：59/0  |  提交时间：2021/11/01